Cardiovascular Patients With no Standard Modifiable Risk Factors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5540 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-22

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Factors in Young Middle Eastern Women With Cardiovascular Disease

NCT04975503

Cardiovascular Diseases Risk Factors

COMPLETED

Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age

NCT05745272

Atherosclerotic Cardiovascular Risk Low-density-lipoprotein (LDL) Cholesterol

TERMINATED

Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease

NCT06655493

Systemic Inflammation (hsCRP)

COMPLETED

National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups

NCT00699959

Coronary Patients Heart Failure

COMPLETED

Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women

NCT00037258

Cardiovascular Diseases Diabetes Mellitus, Non-insulin Dependent Heart Diseases +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, type 2 diabetes mellitus, dyslipidemia, and smoking. These are very common in the Middle East and are crucial to be screened for and addressed in an affective manner.

However, an increasing proportion of patients with ASCVD have none of these individual factors (SMuRF-less). Globally, this proportion comprises 11.6% of individuals with stable coronary disease and heart attack. No prior study has addressed the issue of the prevalence of SMuRF-less patients among the whole population of individuals with ASCVD in the Middle East.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Risk Factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients

Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of atherosclerotic cardiovascular disease (ASCVD).
* Ability to fill the clinical form that evaluates the presence or absence of cardiovascular risk factors including the 4 SMuRFs.